Table 2 Analysis of numerous factors that might be related to overall survival
Number of patients | p-value | |
|---|---|---|
Age | ||
< 65 years | 43 (33%) | <0.05 |
> 65 years | 86 (67%) | <0.05 |
Stage of disease (Salmon-Durie) | ||
I | 8 (6%) | Ns |
II | 20 (16%) | Ns |
III | 101(78%) | <0.05 |
Radiotherapy | ||
Yes | 85 (66%) | Ns |
No | 44 (34%) | Ns |
Time to initial diagnosis | ||
< 1 year | 23 (8%) | Ns |
1–2 years | 48 (37%) | Ns |
> 3 years | 71 (55%) | <0.05 |
CRP level | ||
< 5 mg/l | 91 (70%) | Ns |
> 5 mg/l | 38 (30%) | Ns |
Peripheral blood stem cell transplantation | ||
Yes | 71 (55%) | Ns |
No | 58 (45%) | Ns |
Lactate dehydrogenase | ||
< 240 U/l | 93 (72%) | Ns |
> 240 U/l | 36 (28%) | Ns |
Beta-2 microglobulin | ||
< 3.5 mg/l | 8 (6%) | Ns |
3.5–5.5 mg/l | 31 (24%) | Ns |
> 5.5 mg/l | 90 (70%) | Ns |